The city of Las Vegas, Nevada, currently has 2 active clinical trials seeking participants for Multiple Sclerosis research studies.
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/17/2024
Locations: Cleveland Clinic Foundation, Las Vegas, Nevada
Conditions: Relapsing Multiple Sclerosis
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Recruiting
The DELIVER-MS study seeks to answer the question: Does early treatment with highly effective DMT improve the prognosis for people with MS? This is an area of significant controversy and no data currently exist to guide treatment choices for patients and clinicians. The study results will help guide overall treatment philosophy and will be applicable not only to a wide range of existing therapies but also to new therapies, meeting a significant unmet need in patient decision making and aiding th... Read More
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
08/14/2023
Locations: Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada
Conditions: Multiple Sclerosis, Relapsing-Remitting